Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Net Loans Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

DarioHealth (DRIO) Amortization of Deferred Charges (2019 - 2024)

DarioHealth filings provide 3 years of Amortization of Deferred Charges readings, the most recent being $84000.0 for Q4 2024.

On a quarterly basis, Amortization of Deferred Charges rose 221.74% to $84000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $9000.0, a N/A change, with the full-year FY2024 number at $516000.0, down 56.93% from a year prior.
Amortization of Deferred Charges hit $84000.0 in Q4 2024 for DarioHealth, down from $228000.0 in the prior quarter.
In the past five years, Amortization of Deferred Charges ranged from a high of $228000.0 in Q3 2024 to a low of -$234000.0 in Q3 2023.